After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Surmodics, Inc is $416.68M. A total of 67484.0 shares were traded on the day, compared to an average of 85.33K shares.
In the most recent transaction, Arens Timothy J. sold 7,009 shares of SRDX for 39.44 per share on Nov 26 ’24. After the transaction, the Chief Financial Officer now owns 70,350 company shares. In a previous transaction on Nov 26 ’24, TIMOTHY ARENS bought 7,009 shares at 39.44 per share.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SRDX has a high of $42.44 and a low of $26.00.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SRDX’s latest balance sheet shows that the firm has $38.87M in Cash & Short Term Investments as of fiscal 2021. There were $13.71M in debt and $29.82M in liabilities at the time. Its Book Value Per Share was $7.71, while its Total Shareholder’s Equity was $140.09M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRDX is Buy with a score of 3.67.
